Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
The DOI matches its Crossref record; 493 of the 493 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMechanisms of Drug Release in Nanotherapeutic Delivery SystemsPamela T. Wong and Seok Ki Choi*View Author Information Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States*E-mail: [email protected]. Tel.: (734) 647-0052. Fax: (734) 936-2990.Cite this: Chem. Rev. 2015, 115, 9, 3388–3432Publication Date (Web):April 27, 2015Publication History Received22 August 2014Published online27 April 2015Published inissue 13 May 2015https://pubs.acs.org/doi/10.1021/cr5004634https://doi.org/10.1021/cr5004634review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views14486Altmetric-Citations396LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Drug release,Molecules,Organic compounds,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some authors evaluated the encapsulation efficiency of volatile hydrophilic compounds by Gas Chromatography, since, as a result of drug-polymeric micelle interactions, a decrease of the amount of free volatile compounds in bulk water was found [114].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [114]
Citations
Cites
1 retracted
Items 401–493 of 493
Yassin, M. A., Appelhans, D., Mendes, R. G., Rümmeli, M. H., & Voit, B. I. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201312 · Cited by 58
Lee, S., Lee, O., O’Halloran, T. V., Schatz, G. C., & Nguyen, S. T. (2011) · ACS Nano · doi:10.1021/nn200478m · Cited by 57
Hu, X., Wang, R., Yue, J., Liu, S., Xie, Z., & Jing, X. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm31130e · Cited by 57
Parveen, I., Naughton, D. P., WHISH, W. J. D., & Threadgill, M. D. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00306-6 · Cited by 57
Impact of Dendrimer Surface Functional Groups on the Release of Doxorubicin from Dendrimer Carriers
Zhang, M., Guo, R., Kéri, M., Bányai, I., Zheng, Y. F., Cao, M., Cao, X., & Shi, X. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp411669k · Cited by 57
(2008) · Pan Stanford Publishing eBooks · doi:10.1142/9789814241182 · Cited by 56
Shi, X., Zhang, Z., Guo, R., Wang, Cao, L., & Shen (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24705 · Cited by 56
Rosowsky, A., Forsch, R. A., Uren, J. R., & Wick, M. M. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00144a016 · Cited by 56
Witte, A. B., Timmer, C. M., Gam, J. J., Choi, S. K., Holl, M. M. B., Orr, B. G., Baker, J. R., & Sinniah, K. (2011) · Biomacromolecules · doi:10.1021/bm201566g · Cited by 56
Self-citationPhotochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate
Choi, S. K., Thomas, T. P., Li, M.-H., Desai, A. M., Kotlyar, A., & Baker, J. R. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp05355a · Cited by 56
Self-citationNanoparticle‐Mediated Delivery of Bleomycin
Georgelin, T., Bombard, S., Siaugue, J., & Cabuil, V. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003316 · Cited by 56
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Greenfield, R. S., Griffiths-King, D., Zoeckler, M. E., & Braslawsky, G. R. (1992) · PubMed · Cited by 55
Light‐Activated Transcription and Repression by Using Photocaged SERMs
Shi, Y., & Koh, J. T. (2004) · ChemBioChem · doi:10.1002/cbic.200300823 · Cited by 54
Synthesis and In vitro efficacy of acid-Sensitive poly(ethylene glycol) paclitaxel conjugates
Rodrigues, P. C. A., Scheuermann, K., Stockmar, C., Maier, G., Fiebig, H., Unger, C., Mülhaupt, R., & Kratz, F. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01002-8 · Cited by 52
Development of Protein-Binding Bifunctional Linkers for a New Generation of Dual-Acting Prodrugs
Ajaj, K. A., Biniossek, M. L., & Kratz, F. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800429q · Cited by 52
Wong, B. K., Defeo-Jones, D., Jones, R. E., Garsky, V. M., Feng, D.-M., Oliff, A. I., Chiba, M., Ellis, J. D., & Lin, J. H. (2001) · PubMed · Cited by 52
Yang, K., Weng, L., Cheng, Y., Zhang, H., Zhang, J., Wu, Q., & Xu, T. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp111044k · Cited by 52
Transferrin receptors on the plasma membrane of cultured rat astrocytes
Qian, Z., To, Y., Tang, P., & Feng, Y. (1999) · Experimental Brain Research · doi:10.1007/s002210050916 · Cited by 50
Paclitaxel esters of malic acid as prodrugs with improved water solubility
Damen, E. W. P., Wiegerinck, P. H. G., Braamer, L., Sperling, D., de Vos, D., & Scheeren, H. W. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00301-6 · Cited by 50
Dendrimer-based tumor cell targeting of fibroblast growth factor-1
Thomas, T. P., Shukla, R., Kotlyar, A., Kukowska‐Latallo, J. F., & Baker, J. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.065 · Cited by 49
Inlay, M. A., Choe, V., Bharathi, S., Fernhoff, N. B., Baker, J. R., Weissman, I. L., & Choi, S. K. (2013) · Chemical Communications · doi:10.1039/c3cc42179a · Cited by 47
Self-citationGunaseelan, S., Debrah, O., Wan, L., Leibowitz, M. J., Rabson, A. B., Stein, S., & Sinko, P. J. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0498875 · Cited by 47
Wang, H., Shao, N., Qiao, S.-N., & Cheng, Y. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp3062916 · Cited by 47
Bayer, A. M., Alam, S., Mattern‐Schain, S. I., & Best, M. D. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201304094 · Cited by 47
Macromolecular Anticancer Therapeutics
Reddy, L. H., & Couvreur, P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0507-9 · Cited by 46
Lai, T. C., Cho, H., & Kwon, G. S. (2014) · Polym. Chem. · doi:10.1039/c3py01112g · Cited by 45
Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy
Zheng, Y. F., Fu, F., Zhang, M., Shen, M., Zhu, M., & Shi, X. (2014) · MedChemComm · doi:10.1039/c3md00324h · Cited by 45
Subcellular pH and predicted pH‐dependent features of proteins
Chan, P., Lovrić, J., & Warwicker, J. (2006) · PROTEOMICS · doi:10.1002/pmic.200500534 · Cited by 44
Tian, J., & Stella, V. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21910 · Cited by 44
Dunn, A. E., Dunn, D., Macmillan, A., Whan, R. M., Stait‐Gardner, T., Price, W. S., Lim, M., & Boyer, C. A. (2014) · Polymer Chemistry · doi:10.1039/c4py00150h · Cited by 44
Curran, R. E., Claxton, C. R. J., Hutchison, L., Harradine, P. J., Martin, I. J., & Littlewood, P. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036988 · Cited by 43
Veltkamp, S. A., Witteveen, E. O., Capriati, A., Crea, A., Animati, F., Voogel-Fuchs, M., van den Heuvel, I. J. G. M., Beijnen, J. H., Voest, E. E., & Schellens, J. H. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0438 · Cited by 43
Faal, T., Wong, P. T., Tang, S., Coulter, A., Chen, Y., Tu, C. H., Baker, J. R., Choi, S. K., & Inlay, M. A. (2014) · Molecular BioSystems · doi:10.1039/c4mb00581c · Cited by 42
Self-citationYan, C., Kepa, J. K., Siegel, D. M., Stratford, I. J., & Ross, D. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050401 · Cited by 42
Tao, Y., Han, J., Ye, C., Thomas, T., & Dou, H. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm34042a · Cited by 41
Sideratou, Z., Kontoyianni, C., Drossopoulou, G. I., & Paleos, C. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.058 · Cited by 40
Lin, W., Peng, D., Wang, B., Long, L., Guo, C., & Yuan, J. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200700972 · Cited by 40
Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting
Banquy, X., Leclair, G., Rabanel, J., Argaw, A., Bouchard, J., Hildgen, P., & Giasson, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800257m · Cited by 40
Akinboye, E. S., Rosen, M. D., Denmeade, S. R., Kwabi‐Addo, B., & Bakare, O. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300426q · Cited by 39
Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform
Huang, B., Desai, A. M., Zong, H., Tang, S., Leroueil, P. R., & Baker, J. R. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.12.025 · Cited by 39
Targeted Dendrimer Chemotherapy in an Animal Model for Head and Neck Squamous Cell Carcinoma
Ward, B. B., Dunham, T., Majoros, I. J., & Baker, J. R. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.12.041 · Cited by 39
Glycopeptide dendrimer colchicine conjugates targeting cancer cells
Johansson, E. M. V., Dubois, J., Darbre, T., & Reymond, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.026 · Cited by 39
Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis and in Vitro Evaluation
Ndungu, J. M., Lu, Y., Zhu, S., Yang, C., Wang, X., Chen, G. Z., Shin, D. M., Snyder, J. P., Shoji, M., & Sun, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901763f · Cited by 37
[3H]Methotrexate as a ligand for the folate receptor of Dictyostelium discoideum.
Nandini-Kishore, S. G., & Frazier, W. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7299 · Cited by 37
Light-Activated Gene Expression Directs Segregation of Co-cultured Cells in Vitro
Sauers, D. J., Temburni, M. K., Biggins, J. B., Ceo, L. M., Galileo, D. S., & Koh, J. T. (2010) · ACS Chemical Biology · doi:10.1021/cb9002305 · Cited by 37
Levy, G. A., Adamson, G., Phillips, J. M., Scrocchi, L. A., Fung, L. S., Biessels, P. T. M., Ng, N. F. L., Ghanekar, A., Rowe, A., Xue-Zhong, M., et al. (2006) · Hepatology · doi:10.1002/hep.21072 · Cited by 37
Multivalent Dendrimer Vectors with DNA Intercalation Motifs for Gene Delivery
Wong, P. T., Tang, K., Coulter, A., Tang, S., Baker, J. R., & Choi, S. K. (2014) · Biomacromolecules · doi:10.1021/bm501169s · Cited by 37
Self-citationSelective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin
Wahl, A. F., Donaldson, K. L., Mixan, B. J., Trail, P. A., & Siegall, C. B. (2001) · International Journal of Cancer · doi:10.1002/ijc.1364 · Cited by 36
Possible binding site for paclitaxel at microtubule pores
Magnani, M., Maccari, G., Andreu, J. M., Díaz, J. F., & Botta, M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06994.x · Cited by 36
Schuster, H., Krewer, B., von Hof, J. M., Schmuck, K., Schuberth, I., Alves, F., & Tietze, L. F. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/b925070k · Cited by 35
Binding and Uptake of RGD-Containing Ligands to Cellular α v β 3 Integrins
Cressman, S., Sun, Y. X., Maxwell, E. J., Fang, N., Chen, D. D. Y., & Cullis, P. R. (2008) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-008-9163-y · Cited by 34
Choi, S. K., Thomas, T. P., Leroueil, P. R., Kotlyar, A., Spek, A. F. L. V. D., & Baker, J. R. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp305867v · Cited by 34
Self-citationCrampton, H. L., Hollink, E., Pérez, L. M., & Simanek, E. E. (2007) · New Journal of Chemistry · doi:10.1039/b617875h · Cited by 32
Gee, K. R., Niu, L., Schaper, K., Jayaraman, V., & Hess, G. P. (1999) · Biochemistry · doi:10.1021/bi9826557 · Cited by 32
Hauff, S. J., Raju, S. C., Orosco, R. K., Gross, A. M., Díaz-Pérez, J. A., Savariar, E. N., Nashi, N., Hasselmann, J., Whitney, M. A., Myers, J. N., et al. (2014) · Otolaryngology · doi:10.1177/0194599814545083 · Cited by 32
Temming, K., Lacombe, M., Schaapveld, R. Q. J., Őrfi, L., Kéri, G., Poelstra, K., Molema, G., & Kok, R. J. (2006) · ChemMedChem · doi:10.1002/cmdc.200600201 · Cited by 32
Billington, A. P., Walstrom, K. M., Ramesh, D., Guzikowski, A. P., Carpenter, B. K., & Hess, G. P. (1992) · Biochemistry · doi:10.1021/bi00139a011 · Cited by 31
Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody
Endo, N., Takeda, Y., Kishida, K., Katō, Y., Saito, M., Umemoto, N., & Hara, T. (1987) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199293 · Cited by 30
New quinoline-based caging groups synthesized for photo-regulation of aptamer activity
Li, Y. M., Shi, J. M., Cai, R., Chen, X., Luo, Z., & Guo, Q. (2010) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2010.02.009 · Cited by 29
Umemoto, N., Katō, Y., Endo, N., Takeda, Y., & Hara, T. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430423 · Cited by 28
Specificity and Negative Cooperativity in Dendrimer–Oxime Drug Complexation
Choi, S. K., Leroueil, P. R., Li, M.-H., Desai, A. M., Zong, H., Spek, A. F. L. V. D., & Baker, J. R. (2011) · Macromolecules · doi:10.1021/ma200522m · Cited by 28
Self-citationThe Pharmacological Profile and Clinical Use of Mesalazine (5-Aminosalicylic Acid)
Klotz, U. E. (2012) · Arzneimittelforschung · doi:10.1055/s-0031-1299685 · Cited by 28
Plantinga, A., Witte, A. B., Li, M.-H., Harmon, A., Choi, S. K., Holl, M. M. B., Orr, B. G., Baker, J. R., & Sinniah, K. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100296z · Cited by 27
Self-citationPhelps, M. A., Foraker, A. B., Gao, W., Dalton, J. T., & Swaan, P. W. (2004) · Molecular Pharmaceutics · doi:10.1021/mp0499510 · Cited by 27
Thomas, T. P., Joice, M. V., Sumit, M., Silpe, J. E., Kotlyar, A., Bharathi, S., Kukowska‐Latallo, J. F., Baker, J. R., & Choi, S. K. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319370004 · Cited by 27
Self-citationMajoros, I., & Baker, J. (2008) · doi:10.1201/9780367806088 · Cited by 27
Felsen, C. N., Savariar, E. N., Whitney, M. A., & Tsien, R. Y. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00371.2013 · Cited by 26
Herrador, J. M. H., Zbuzek, M., Černý, R., & Jíša, P. (2013) · Open Chemistry · doi:10.2478/s11532-013-0365-6 · Cited by 25
Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs
Huang, B., Tang, S., Desai, A. M., Cheng, X.-M., Kotlyar, A., Spek, A. V. D., Thomas, T. P., & Baker, J. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.061 · Cited by 24
Han, S.-J. L. J. (2001) · Drug Delivery · doi:10.1080/107175401316906883 · Cited by 24
Wang, B., Liu, S., & Borchardt, R. T. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00108a013 · Cited by 24
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?
Lakatos, P. L., & Lakatos, L. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.08.003 · Cited by 23
The 9-xanthenylmethyl group: a novel photocleavable protecting group for amines
Du, H., & Boyd, M. K. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)01370-3 · Cited by 23
Bilalis, P., Efthimiadou, E. Κ., Chatzipavlidis, A., Boukos, N. K., & Kordas, G. C. (2012) · Polymer International · doi:10.1002/pi.4152 · Cited by 23
Qvit, N., Monderer‐Rothkoff, G., Ido, A., Shalev, D. E., Amster‐Choder, O., & Gilon, C. (2008) · Biopolymers · doi:10.1002/bip.21010 · Cited by 21
Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems
Naughton, D. P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00229-0 · Cited by 20
Manabe, Y., Tsubota, T., Haruta, Y., Kataoka, K., Okazaki, M., Haisa, S., Nakamura, K., & Kimura, I. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90140-6 · Cited by 20
Chiang, W., Huang, W., Shen, M., Wang, C.-H., Huang, Y., Lin, S., Chern, C., & Chiu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092268 · Cited by 20
Cogan, P. S., & Koch, T. H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0495226 · Cited by 17
Azobenzene functionalized mesoporous AlMCM-41-type support for drug release applications
Mitran, R., Berger, D., Băjenaru, L., Năstase, S., Andronescu, C., & Matei, C. (2014) · Open Chemistry · doi:10.2478/s11532-014-0534-2 · Cited by 17
Heptameric Targeting Ligands against EGFR and HER2 with High Stability and Avidity
Kim, D., Yan, Y., Valencia, C. A., & Liu, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043077 · Cited by 17
Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen
Wu, L. Y., Jacinda, C., Kazak, M., Page, H., Toriyabe, Y., Anderson, M. O., & Berkman, C. E. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.096 · Cited by 16
No reduction of α-tocopherol quinone by glutathione in rat liver microsomes
van Haaften, R. I. M., Evelo, C. T., Haenen, G. R. M. M., & Bast, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00545-7 · Cited by 16
Yoon, K. J. P., Krull, E. J., Morton, C. L., Bornmann, W. G., Lee, R. E., Potter, P. M., & Danks, M. K. (2003) · PubMed · Cited by 15
Ferrer, S. F., Naughton, D. P., & Threadgill, M. D. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00481-2 · Cited by 14
Mortellaro, M. A., Bleisch, T. J., Duerr, B. F., Kang, M. S., Huang, H., & Czarnik, A. W. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00127a032 · Cited by 12
Reprogramming Cellular Signaling Machinery Using Surface-Modified Carbon Nanotubes
Zhang, Y., Wu, L., Jiang, C., & Yan, B. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500480d · Cited by 10
Np, M., Sw, G., & Threadgill, M. D. (1998) · PubMed · Cited by 10
Stefano, G. D., Lanza, M., Busi, C., Barbieri, L. L., & FIUME, L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.638 · Cited by 9
The Effect of Charge on the Volume Change of DNA Binding with Intercalator DAPP
Shi, X., & Macgregor, R. B. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp068424o · Cited by 7
PMX-622 (Polymyxin B-Dextran 70) Does Not Alter In Vitro Activities of 11 Antimicrobial Agents
FUCHS, P. C., Barry, A. L., & Brown, S. D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2765 · Cited by 7
Shan, D., Zheng, A., BALLARD, E. C., Wang, W., Borchardt, R. T., & Wang, B. (2000) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.48.238 · Cited by 4
(1989) · PubMed
Research works printed but not linked: 47
- Majoros I. J., 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 502
- Fischer M., 1999, Angew. Chem., Int. Ed., 38, 884, 10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · DOI · Paper page
- Maeda H., 1989, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
- Raha S., 2010, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 3, 269
- Bhaskar V., 2003, Cancer Res., 63, 6387
- Hong S., 2007, Chem. Biol. (Oxford, U. K.), 14, 107
- Choi Y., 2005, Chem. Biol. (Oxford, U. K.), 12, 35
- Yellepeddi V. K., 2009, Anticancer Res., 29, 2933
- Maturo J., 1988, Biochem. Pharmacol. (Amsterdam, Neth.), 37, 3755
- de Groot F. M. H., 2002, Mol. Cancer Ther., 1, 901
- Bosnjakovic A., 2011, Nanomedicine (N. Y., NY, U. S.), 7, 284
- Levy G. A., 2006, Hepatology (Hoboken, NJ, U. S.), 43, 581
- Mahajan S. D., 2012, Methods in Enzymology, 509
- Salvi A., 1997, Drug Metab. Dispos., 25, 395
- Sanghani S. P., 2003, Clin. Cancer Res., 9, 4983
- Yoon K. J. P., 2003, Mol. Cancer Ther., 2, 1171
- Tougou K., 1998, Drug Metab. Dispos., 26, 355
- Barnes K. R., 2004, Chem. Biol. (Oxford, U. K.), 11, 557
- DeFeo-Jones D., 2000, Nat. Med. (N. Y., NY, U. S.), 6, 1248
- Wong B. K., 2001, Drug Metab. Dispos., 29, 313
- Hervio L. S., 2000, Chem. Biol. (Oxford, U. K.), 7, 443
- Silver D. A., 1997, Clin. Cancer Res., 3, 81
- Felsen C. N., 2014, Am. J. Physiol.: Lung Cell. Mol. Physiol., 306, L764
- Butler P. J., 1967, Biochem. J., 103, 78b
- Schmalfeldt B., 2001, Clin. Cancer Res., 7, 2396
- Incorvaia L., 2007, Anticancer Res., 27, 1519
- Trail P. A., 1992, Cancer Res., 52, 5693
- Hinman L. M., 1993, Cancer Res., 53, 3336
- Mahmud N. P., 1998, Anti-Cancer Drug Des., 13, 655
- Hunter F. W., 2012, Biochem. Pharmacol. (Amsterdam, Neth.), 83, 574
- van Haaften R. I. M., 2001, Biochem. Pharmacol. (Amsterdam, Neth.), 61, 715
- Rodrigues M. L., 1995, Cancer Res., 55, 63
- Rodrigues M. L., 1995, Chem. Biol. (Oxford, U. K.), 2, 223
- Goard M., 2005, Chem. Biol. (Oxford, U. K.), 12, 685
- Chourasia M. K., 2003, J. Pharm. Pharm. Sci., 6, 33
- Berchane N. S., 2007, Int. J. Pharm. (Amsterdam, Neth.), 337, 118
- Zhang M., 2011, Int. J. Nanomed., 6, 2337
- Kommareddy S., 2007, Nanomedicine (N. Y., NY, U. S.), 3, 32
- Mitran R.-A., 2014, Cent. Eur. J. Chem., 12, 1
- Wu C., 2011, Int. J. Pharm. (Amsterdam, Neth.), 403, 162
- Nelson J. L., 2002, Cancer Res., 62, 7280
- Li C., 1998, Cancer Res., 58, 2404
- Seymour L. W., 2002, J. Clin. Oncol., 20, 1668, 10.1200/jco.2002.20.6.1668 · doi:10.1200/jco.2002.20.6.1668 · Paper page
- Vasey P. A., 1999, Clin. Cancer Res., 5, 83
- Yokoyama M., 1991, Cancer Res., 51, 3229
- Wosikowski K., 2003, Clin. Cancer Res., 9, 1917
- Yurkovetskiy A., 2010, Cancer Res., 70
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, F., Dehghan, G., Ghaffari, M., Yekta, R., Abbaspour-Ravasjani, S., Baradaran, B., Ezzati Nazhad Dolatabadi, J., & Hamblin, M. R. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.05.002 · Cited by 487
“However, the pH dependent cleavage of amide linkers including cis-aconityl, citraconyl and maleyl groups has been explored in controlled drug release [61].”
BackgroundTumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Metadata
- Authors
- Wong, P. T., & Choi, S. K.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Choi, Seok Ki
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-27
- Volume
- 115
- Issue
- 9
- Pages
- 3388-3432
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2053890812
- Cited by
- 507
- References
- 493
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 31 · 2023: 45 · 2022: 35 · 2021: 51 · 2020: 59 · 2019: 64 · 2018: 60 · 2017: 48 · 2016: 40 · 2015: 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of the Vice President for Research, University of Michigan
- Shanghai Jiao Tong University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug release mechanism, nanomedicine, controlled drug release, anticancer agents, nanocarriers
- MeSH terms
- Theranostic Nanomedicine, Animals, Drug Carriers, Humans, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.